Formulation R (G&W Laboratories, Inc.)


Welcome to the PulseAid listing for the Formulation R drug offered from G&W Laboratories, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: G&W Laboratories, Inc.
NON-PROPRIETARY NAME: Phenylephrine Hydrochloride, Hydrogenate Palm Kernel Oil
SUBSTANCE NAME: PHENYLEPHRINE HYDROCHLORIDE; HYDROGENATED PALM KERNEL OIL
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: RECTAL
DOSAGE FORM: SUPPOSITORY
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2002-06-24
END MARKETING DATE: 0000-00-00


Formulation R HUMAN OTC DRUG Details:

Item DescriptionFormulation R from G&W Laboratories, Inc.
LABELER NAME: G&W Laboratories, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 2.5; 855(mg/1; mg/1)
START MARKETING DATE: 2002-06-24
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0713-0535_17cecb0a-0c16-cdda-744e-a3dea9333e1e
PRODUCT NDC: 0713-0535
APPLICATION NUMBER: part346

Other PHENYLEPHRINE HYDROCHLORIDE; HYDROGENATED PALM KERNEL OIL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
G&W Laboratories, Inc.Formulation R